Previous 10 | Next 10 |
We conclude our roundtable series with Biotech and Healthcare coverage. Seven of our Marketplace contributors give their analysis and share one top idea. Look for more roundtables and analysis this summer from our community of 180+ Marketpalce services. ~ By Tim Murphy, Ma...
Meridian saw a huge jump in earnings once the pandemic set in. Investors may worry that as the pandemic eases away, those earnings will also fall. I believe that worry is unfounded. For further details see: Meridian Bioscience: Correctly Valued
Wall Street ended an uncertain session with mild losses on Wednesday. The lack of direction came as investors digested new commentary from Federal Reserve Chairman Jerome Powell. While the stock market finished near the unchanged market, many commodities came under serious pressure. This incl...
Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular Assays PR Newswire CINCINNATI , June 20, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing s...
Stocks suffered a setback on Wednesday, losing ground after two days of modest gains. Overall, the major averages continue to show a lack of direction, as investors remain worried about inflation, interest rates and the possibility of an eventual recession. Scotts Miracle-Gro (NYSE:SMG) was a...
Diagnostics and molecular reagents company Meridian Bioscience (NASDAQ:VIVO) hit a 52-week high of $28.93 on Wednesday. As of Wednesday morning, the stock is up 36% year to date. Meridian (VIVO) has benefitted from a strong demand for reagents associated with COVID-19 antigen testin...
Meridian Bioscience (NASDAQ:VIVO) said that its qPCR master mixes can be used to develop molecular diagnostic tests that can detect monkeypox. The company said its inhibitor-tolerant qPCR master mixes are ideal for the detection of monkeypox. Meridian (VIVO) added that qPCR detection is ...
Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular Tests PR Newswire CINCINNATI , May 26, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global pr...
Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference PR Newswire CINCINNATI , May 23, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and ...
Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic Assays Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for ...
News, Short Squeeze, Breakout and More Instantly...
Meridian Bioscience Inc. Company Name:
VIVO Stock Symbol:
NASDAQ Market:
Meridian Bioscience Inc. Website:
The worldwide smartphone market has recently experienced a notable upturn in sales. October saw a 5% year-on-year growth, breaking a 27-...
Apple Inc. (NASDAQ:AAPL) has once again emerged as the most resilient smartphone maker in the world, reporting the slowest decline in iPhone shipme...
Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...